Dr. Michael Pearlman, MD
Claim this profileColorado Neurological Institute
Studies Glioblastoma
Studies Recurrence
4 reported clinical trials
6 drugs studied
Area of expertise
1Glioblastoma
MET positive
MET negative
2Recurrence
MET positive
MET negative
Affiliated Hospitals
More about Michael Pearlman, MD
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Michael Pearlman, MD has experience with
- DCVax®-L
- OKN-007
- Temozolomide
- Berubicin
- Lomustine
- Optune®
Breakdown of trials Michael Pearlman, MD has run
Glioblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael Pearlman, MD specialize in?
Michael Pearlman, MD focuses on Glioblastoma and Recurrence. In particular, much of their work with Glioblastoma has involved MET positive patients, or patients who are MET negative.
Is Michael Pearlman, MD currently recruiting for clinical trials?
No, Michael Pearlman, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Michael Pearlman, MD has studied deeply?
Yes, Michael Pearlman, MD has studied treatments such as DCVax®-L, OKN-007, Temozolomide.
What is the best way to schedule an appointment with Michael Pearlman, MD?
Apply for one of the trials that Michael Pearlman, MD is conducting.
What is the office address of Michael Pearlman, MD?
The office of Michael Pearlman, MD is located at: Colorado Neurological Institute, Englewood, Colorado 80113 United States. This is the address for their practice at the Colorado Neurological Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.